Veradermics, Incorporated (NYSE:MANE – Get Free Report)’s share price traded down 4.4% during trading on Monday . Leerink Partners raised their target price on Veradermics from $75.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Needham & Company LLC increased their price target on Veradermics from $136.00 to $164.00 and gave the stock a “buy” rating in a research note on Wednesday, July 15th. Seven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Get Veradermics alerts:View Our Latest Stock Report on MANEVeradermics Stock PerformanceThe company has a 50-day simple moving average of $108.10.